Neoadjuvant and Adjuvant Fenretinide Compared With Adjuvant Fenretinide Alone in Treating Patients Who Are Undergoing Surgical Resection For Recurrent Glioblastoma Multiforme

NCT00075491 · clinicaltrials.gov ↗

PHASE2

Phase

TERMINATED

Status

42

Enrollment

NIH

Sponsor class

Stopped Administratively complete.

Conditions

Adult Giant Cell Glioblastoma
Adult Glioblastoma
Adult Gliosarcoma
Recurrent Adult Brain Tumor

Interventions

DRUG: fenretinide
PROCEDURE: therapeutic conventional surgery
OTHER: pharmacological study
OTHER: laboratory biomarker analysis

Sponsor

National Cancer Institute (NCI)